Vitamin D receptor activation reduces inflammatory cytokines and plasma MicroRNAs in moderate chronic kidney disease – a randomized trial

BACKGROUND: Chronic kidney disease (CKD) is a major risk factor for cardiovascular disease (CVD), partly due to endothelial dysfunction and chronic inflammation. Vitamin D treatment in end stage renal disease is suggested to modulate the immune system and lead to improved outcomes. We and others hav...

Descripción completa

Detalles Bibliográficos
Autores principales: Mansouri, Ladan, Lundwall, Kristina, Moshfegh, Ali, Jacobson, Stefan H., Lundahl, Joachim, Spaak, Jonas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5434555/
https://www.ncbi.nlm.nih.gov/pubmed/28511692
http://dx.doi.org/10.1186/s12882-017-0576-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5434555/
https://www.ncbi.nlm.nih.gov/pubmed/28511692
http://dx.doi.org/10.1186/s12882-017-0576-8

Ejemplares similares